The clinical development of vaccines for HER2<sup>+</sup> breast cancer: Current landscape and future perspectives.

Costa, R L B; Soliman, H; Czerniecki, B J

The clinical development of vaccines for HER2⁺ breast cancer: Current landscape and future perspectives.

Costa, R L B; Soliman, H; Czerniecki, B J.

Affiliation

Costa RLB; Lee Moffitt Cancer Center, Department of Breast Cancer, Tampa, United States. Electronic address: ricardo.costa@moffitt.org.
Soliman H; Lee Moffitt Cancer Center, Department of Breast Cancer, Tampa, United States.
Czerniecki BJ; Lee Moffitt Cancer Center, Department of Breast Cancer, Tampa, United States.

Cancer Treat Rev ; 61: 107-115, 2017 Dec.

Article in En | MEDLINE | ID: mdl-29125981

Subject(s)

Breast Neoplasms/therapy; Cancer Vaccines/administration & dosage; Cancer Vaccines/immunology; Receptor, ErbB-2/immunology; Breast Neoplasms/immunology; Female; Humans; Immunotherapy, Active/methods; Immunotherapy, Active/trends; Molecular Targeted Therapy; Th1 Cells/immunology; Th2 Cells/immunology

Key words

Breast cancer; Dendritic cells; HER2; Immune therapy; Vaccines

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Receptor, ErbB-2 / Cancer Vaccines Limits: Female / Humans Language: En Journal: Cancer Treat Rev Year: 2017 Document type: Article Country of publication: Netherlands

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google